A Study of LUCAR-G79 in Subjects With Relapsed/Refractory Autoimmune Diseases
Clinical trial NCT07049081 · TERMINATED
Trial details
- NCT number
- NCT07049081
- Sponsor
- Nanjing Legend Biotech Co.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-17
- Primary completion
- 2026-03-20
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.